CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Lidocaine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02396537
NCT02396537N/ACompleted
CompareCT.gov

Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration: A Double-blind, Randomized, Placebo-controlled Trial

University of Alabama at Birmingham·interventional·Posted Mar 24, 2015·Updated Feb 23, 2017

In Brief

A clinical study evaluating Lidocaine, Midazolam, and 1 other intervention for Pain. Completed, enrolled 77 participants.

Detailed Summary

The purpose of this study was to establish whether premedication with topical lidocaine would reduce the pain associated with IN midazolam administration in children. The study was designed to be a double-blinded, randomized, placebo-controlled trial performed in an urban, academic pediatric emergency department.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 24, 2015
Enrollment StartJan 1, 2014
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago

Interventions

Lidocainedrug

Administered intranasally prior to Midazolam administration.

Midazolamdrug

Administered to all patients immediately after study drug (Lidocaine or Placebo) administered.

0.9% Salinedrug

Administered intranasally prior to Midazolam administration.